Hypertension and Related Cardiovascular Disease Burden in China

<p>Background</p><p>With rapid economic development, urbanization, and an aging population, cardiovascular diseases (CVDs) have become the leading cause of death in China.</p><p>Objectives</p><p>The aim of this study was to provide a comprehensive review on...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joshua D. Bundy, Jiang He
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2016
Materias:
Acceso en línea:https://doaj.org/article/7b0da108ae1c473490e7fb851fa1ce41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7b0da108ae1c473490e7fb851fa1ce41
record_format dspace
spelling oai:doaj.org-article:7b0da108ae1c473490e7fb851fa1ce412021-12-02T04:22:18ZHypertension and Related Cardiovascular Disease Burden in China2214-999610.1016/j.aogh.2016.02.002https://doaj.org/article/7b0da108ae1c473490e7fb851fa1ce412016-06-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/741https://doaj.org/toc/2214-9996<p>Background</p><p>With rapid economic development, urbanization, and an aging population, cardiovascular diseases (CVDs) have become the leading cause of death in China.</p><p>Objectives</p><p>The aim of this study was to provide a comprehensive review on the prevalence, awareness, treatment, and control of hypertension (HTN) as well as blood pressure (BP)-related morbidity and mortality of CVD in Chinese adults over time.</p><p>Findings</p><p>The prevalence of HTN in China is high and increasing. Recent estimates are variable but indicate 33.6% (35.3% in men and 32% in women) or 335.8 million (178.6 million men and 157.2 million women) of the Chinese adult population had HTN in 2010, which represents a significant increase from previous surveys. BP-related CVD remains the leading cause of death in Chinese adults, with stroke being the predominant cause of cardiovascular deaths. Of those with HTN, 33.4% (30.4% in men and 36.7% in women) were aware of their condition, 23.9% (20.6% in men and 27.7% in women) were treated, and only 3.9% (3.5% in men and 4.3% in women) were controlled to the currently recommended target of BP <140/90 mm Hg. Awareness and treatment of HTN have improved over time, but HTN control has not. Geographic differences in the prevalence, awareness, treatment, and control of HTN are evident, both in terms of a north-south gradient and urban-rural disparity.</p><p>Conclusions</p>The prevalence of HTN is high and increasing, while the control rate is low in Chinese adults. Combatting HTN and BP-related morbidity and mortality will require a comprehensive approach at national and local levels. The major challenge moving forward is to develop and implement effective, practical, and sustainable prevention and treatment strategies in China.Joshua D. BundyJiang HeUbiquity Pressarticlehypertensioncardiovascular diseasemortalityprevalencetreatmentcontrolChinaInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 82, Iss 2, Pp 227-233 (2016)
institution DOAJ
collection DOAJ
language EN
topic hypertension
cardiovascular disease
mortality
prevalence
treatment
control
China
Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
spellingShingle hypertension
cardiovascular disease
mortality
prevalence
treatment
control
China
Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Joshua D. Bundy
Jiang He
Hypertension and Related Cardiovascular Disease Burden in China
description <p>Background</p><p>With rapid economic development, urbanization, and an aging population, cardiovascular diseases (CVDs) have become the leading cause of death in China.</p><p>Objectives</p><p>The aim of this study was to provide a comprehensive review on the prevalence, awareness, treatment, and control of hypertension (HTN) as well as blood pressure (BP)-related morbidity and mortality of CVD in Chinese adults over time.</p><p>Findings</p><p>The prevalence of HTN in China is high and increasing. Recent estimates are variable but indicate 33.6% (35.3% in men and 32% in women) or 335.8 million (178.6 million men and 157.2 million women) of the Chinese adult population had HTN in 2010, which represents a significant increase from previous surveys. BP-related CVD remains the leading cause of death in Chinese adults, with stroke being the predominant cause of cardiovascular deaths. Of those with HTN, 33.4% (30.4% in men and 36.7% in women) were aware of their condition, 23.9% (20.6% in men and 27.7% in women) were treated, and only 3.9% (3.5% in men and 4.3% in women) were controlled to the currently recommended target of BP <140/90 mm Hg. Awareness and treatment of HTN have improved over time, but HTN control has not. Geographic differences in the prevalence, awareness, treatment, and control of HTN are evident, both in terms of a north-south gradient and urban-rural disparity.</p><p>Conclusions</p>The prevalence of HTN is high and increasing, while the control rate is low in Chinese adults. Combatting HTN and BP-related morbidity and mortality will require a comprehensive approach at national and local levels. The major challenge moving forward is to develop and implement effective, practical, and sustainable prevention and treatment strategies in China.
format article
author Joshua D. Bundy
Jiang He
author_facet Joshua D. Bundy
Jiang He
author_sort Joshua D. Bundy
title Hypertension and Related Cardiovascular Disease Burden in China
title_short Hypertension and Related Cardiovascular Disease Burden in China
title_full Hypertension and Related Cardiovascular Disease Burden in China
title_fullStr Hypertension and Related Cardiovascular Disease Burden in China
title_full_unstemmed Hypertension and Related Cardiovascular Disease Burden in China
title_sort hypertension and related cardiovascular disease burden in china
publisher Ubiquity Press
publishDate 2016
url https://doaj.org/article/7b0da108ae1c473490e7fb851fa1ce41
work_keys_str_mv AT joshuadbundy hypertensionandrelatedcardiovasculardiseaseburdeninchina
AT jianghe hypertensionandrelatedcardiovasculardiseaseburdeninchina
_version_ 1718401318834405376